Audentes Therapeutics Inc
Change company Symbol lookup
Select an option...
BOLD Audentes Therapeutics Inc
CBZ CBIZ Inc
IMLFF InMed Pharmaceuticals Inc
PNW Pinnacle West Capital Corp
AAPL Apple Inc
NAII Natural Alternatives International Inc
SJMiv.P Invesco BulletShares 2022 Hi Yld Corp Bd ETF
INTC Intel Corp
VAL Valaris PLC
GE General Electric Co
Go

Health Care : Biotechnology | Small Cap GrowthCompany profile

Audentes Therapeutics, Inc. is an early-stage biotechnology company. The Company is focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects. The Company has a portfolio of product candidates, including AT132 for the treatment of X-Linked Myotubular Myopathy (XLMTM); AT342 for the treatment of Crigler-Najjar Syndrome (Crigler-Najjar); AT982 for the treatment of Pompe disease, and AT307 for the treatment of the CASQ2 subtype of Catecholaminergic Polymorphic Ventricular Tachycardia (CASQ2-CPVT). The Company's subsidiary is Audentes Therapeutics UK Ltd. As of September 30, 2016, the Company had not generated any revenues.

Closing Price
$59.32
Day's Change
0.07 (0.12%)
Bid
--
Ask
--
B/A Size
--
Day's High
59.48
Day's Low
59.24
Volume
(Light)
Volume:
2,143,238

10-day average volume:
3,894,999
2,143,238
  • Prev Close
    59.25
  • Today's Open
    59.25
  • Day's Range
    59.24-59.48
  • Avg Vol (10-day)
    3.9M
  • Last (time)
    4:00p ET 12/09/19
  • Last (size)
    10.8K
  • 52-Wk Range
    17.95 - 59.48
    LowHigh
  • (12/26/18 - 12/09/19)
    0.27%
  • 88.3%
  • Market Cap
    2.7B
  • Shares Outstanding
    45.9M
  • -3.98
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.6
  • 101.41
  • (% of float 11/15/19)
    5.53

Latest News

December 09, 2019
6:04 pm ET
MarketWatch
December 06, 2019
8:03 pm ET
PR Newswire
6:42 am ET
MarketWatch
December 04, 2019
8:30 am ET
PR Newswire
December 03, 2019
7:13 pm ET
PR Newswire
11:35 am ET
PR Newswire
11:11 am ET
MarketWatch
10:14 am ET
MarketWatch
10:11 am ET
MarketWatch
9:21 am ET
MarketWatch
8:58 am ET
MarketWatch
8:26 am ET
MarketWatch
December 02, 2019
11:10 pm ET
Globe Newswire
6:01 pm ET
BusinessWire
November 26, 2019
4:03 pm ET
BusinessWire
November 19, 2019
7:41 am ET
MarketWatch
7:40 am ET
MarketWatch
November 07, 2019
4:01 pm ET
BusinessWire
October 31, 2019
7:17 am ET
BusinessWire
October 05, 2019
7:01 am ET
BusinessWire
October 04, 2019
6:00 pm ET
BusinessWire
October 01, 2019
8:00 am ET
BusinessWire
September 30, 2019
8:00 am ET
BusinessWire
November 26, 2018
7:14 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.